Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

TG Therapeutics Inc (NASDAQ:TGTX)

5.50
Delayed Data
As of Dec 02
 +0.05 / +0.92%
Today’s Change
4.90
Today|||52-Week Range
14.80
-53.90%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2012

2013

2014

2015
Revenue and IncomeNet Revenues19.0K152.4K152.4K152.4K
 
 
 
 
 
Depreciation And Amortization235.001.1K3.9K15.5K
 
 
 
 
 
 
Operating ExpensesGross Income----------
General Expenses25.8M20.3M55.9M63.3M
 
 
 
 
 
Research And Development21.0M13.7M40.1M47.7M
 
 
 
 
 
Total Operating Expenses25.8M20.3M55.9M63.3M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-25.8M-20.2M-55.7M-63.2M
 
 
 
 
 
Extraordinary Credit1.7M3.3M720.0K1.0M
 
 
 
 
 
Extraordinary Charge-1.1M-2.8M0.000.00
 
 
 
Interest Expense On Debt905.7K952.9K930.7K972.7K
 
 
 
 
 
Other Expenses272.2K108.9K95.4K0.00
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-25.9M-20.5M-55.8M-62.9M
 
 
 
 
 
Income Taxes-330.0K0.000.000.00
 
 
Minority Interest-8.1M0.000.000.00
 
 
Net Income-18.1M-20.5M-55.8M-62.9M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS13.1M25.4M34.1M45.6M
 
 
 
 
 
Shares To Calculate EPS Diluted13.1M25.4M34.1M45.6M
 
 
 
 
 
 
Earnings Per ShareEPS-$1.38-$0.81-$1.64-$1.38
 
 
 
 
 
EPS Diluted-$1.38-$0.81-$1.64-$1.38